Coherus Oncology, Inc. (CHRS) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -132.13M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-132.13M | (m) |
| 2026-03-31 | (m) | $186.27M | (m) |
| 2025-12-31 | (m) | $168.02M | (m) |
| 2025-09-30 | (m) | $154.97M | (m) |
| 2025-06-30 | (m) | $179.75M | (m) |
| 2025-03-31 | (m) | $-130.94M | (m) |
| 2024-12-31 | (m) | $28.51M | (m) |
| 2024-09-30 | (m) | $-450.00K | (m) |
| 2024-06-30 | (m) | $-29.34M | (m) |
| 2024-03-31 | (m) | $-59.29M | (m) |
| 2023-12-31 | (m) | $-237.89M | (m) |
| 2023-09-30 | (m) | $-217.11M | (m) |
| 2023-06-30 | (m) | $-264.12M | (m) |
| 2023-03-31 | (m) | $-271.40M | (m) |
| 2022-12-31 | (m) | $-291.75M | (m) |
| 2022-09-30 | (m) | $-278.61M | (m) |
| 2022-06-30 | (m) | $-230.49M | (m) |
| 2022-03-31 | (m) | $-210.24M | (m) |
| 2021-12-31 | (m) | $-287.10M | (m) |
| 2021-09-30 | (m) | $-231.67M | (m) |
| 2021-06-30 | (m) | $-165.21M | (m) |
| 2021-03-31 | (m) | $-76.28M | (m) |
| 2020-12-31 | (m) | $132.24M | (m) |
| 2020-09-30 | (m) | $161.76M | (m) |
| 2020-06-30 | (m) | $180.87M | (m) |
| 2020-03-31 | (m) | $145.41M | (m) |
| 2019-12-31 | (m) | $89.83M | (m) |
| 2019-09-30 | (m) | $-11.99M | (m) |
| 2019-06-30 | (m) | $-117.84M | (m) |
| 2019-03-31 | (m) | $-185.05M | (m) |
| 2018-12-31 | (m) | $-209.34M | (m) |
| 2018-09-30 | (m) | $-195.81M | (m) |
| 2018-06-30 | (m) | $-195.99M | (m) |
| 2018-03-31 | (m) | $-207.69M | (m) |
| 2017-12-31 | (m) | $-238.17M | (m) |
| 2017-09-30 | (m) | $-265.02M | (m) |
| 2017-06-30 | (m) | $-122.10M | (m) |
| 2017-03-31 | (m) | $-136.73M | (m) |
| 2016-12-31 | (m) | $-127.34M | (m) |
| 2016-09-30 | (m) | $-103.81M | (m) |
| 2016-06-30 | (m) | $-259.08M | (m) |
| 2016-03-31 | (m) | $-247.92M | (m) |
| 2015-12-31 | (m) | $-223.26M | (m) |
| 2015-09-30 | (m) | $-200.00M | (m) |
| 2015-06-30 | (m) | $-136.54M | (m) |
| 2015-03-31 | (m) | $-102.69M | (m) |
| 2014-12-31 | (m) | $-87.13M | (m) |
| 2014-09-30 | (m) | (m) | (m) |
| 2014-06-30 | (m) | $-86.19M | (m) |
| 2014-03-31 | (m) | $-69.94M | (m) |
| 2013-12-31 | (m) | $-53.63M | (m) |
| 2013-09-30 | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) |
| 2012-12-31 | (m) | $-33.02M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |